AMANDA BEAR: Open Payments
NPI 1649529884 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,429 in 211 payments from 36 companies in 2025. Trend: 2023 $3,912 · 2024 $4,470 · 2025 $5,429
Food & beverage: $4,634Consulting: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $1,027 |
| Lundbeck LLC | 10 | $976 |
| Lilly USA, LLC | 11 | $538 |
| PFIZER INC. | 39 | $390 |
| JAZZ PHARMACEUTICALS INC. | 14 | $375 |
| Axsome Therapeutics, Inc. | 7 | $303 |
| Novartis Pharmaceuticals Corporation | 9 | $286 |
| Eisai Inc. | 6 | $235 |
| SK Life Science, Inc. | 4 | $123 |
| Teva Pharmaceuticals USA, Inc. | 3 | $97 |
Products named: VYEPTI, QULIPTA, KISUNLA, NURTEC ODT, KESIMPTA, Symbravo, XYWAV, BOTOX.
Industry payments across FL — which companies pay providers there.
